{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T22:59:38Z","timestamp":1793314778515,"version":"4.5.0"},"reference-count":135,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T00:00:00Z","timestamp":1759622400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Infectious Medicine"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.imj.2025.100211","type":"journal-article","created":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T00:40:45Z","timestamp":1759797645000},"page":"100211","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Immune dysregulation in type 2 diabetes mellitus: Implications for tuberculosis, COVID-19, and HIV\/AIDS"],"prefix":"10.1016","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0517-247X","authenticated-orcid":false,"given":"Uzair","family":"Abbas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harendra","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niaz","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7101-9265","authenticated-orcid":false,"given":"Ishfaque","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rabeel Nawaz","family":"Laghari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Misha","family":"Tanveer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Hadif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kashaf","family":"Fatima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhib Ullah","family":"Khalid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-6078-2800","authenticated-orcid":false,"given":"Khadija","family":"Anwar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahtab","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.imj.2025.100211_bib0001","doi-asserted-by":"crossref","first-page":"107","DOI":"10.2991\/jegh.k.191028.001","article-title":"Epidemiology of type 2 diabetes\u2014Global burden of disease and forecasted trends","volume":"10","author":"Abdul Basith Khan","year":"2020","journal-title":"J Epidemiol Glob Health"},{"issue":"3","key":"10.1016\/j.imj.2025.100211_bib0002","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/ng0793-305","article-title":"Susceptibility to insulin dependent diabetes mellitus maps to a 4.1 kb segment of DNA spanning the insulin gene and associated VNTR","volume":"4","author":"Lucassen","year":"1993","journal-title":"Nat Genet"},{"issue":"4","key":"10.1016\/j.imj.2025.100211_bib0003","first-page":"838","article-title":"Prevalence of frozen shoulder among patients with diabetes: a single center experience from Karachi, Pakistan","volume":"45","author":"Ahmad","year":"2020","journal-title":"Rawal Med J"},{"key":"10.1016\/j.imj.2025.100211_bib0004","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.biopha.2018.02.103","article-title":"The potential pathogenic role of IL-17\/Th17 cells in both type 1 and type 2 diabetes mellitus","volume":"101","author":"Abdel-Moneim","year":"2018","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.imj.2025.100211_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2021.154795","article-title":"Understanding the increased risk of infections in diabetes: innate and adaptive immune responses in type 1 diabetes","volume":"121","author":"Janssen","year":"2021","journal-title":"Metabolism"},{"issue":"3","key":"10.1016\/j.imj.2025.100211_bib0006","doi-asserted-by":"crossref","first-page":"692","DOI":"10.2337\/dc21-2102","article-title":"Inflammation, hyperglycemia, and adverse outcomes in individuals with diabetes mellitus hospitalized for COVID-19","volume":"45","author":"Vasbinder","year":"2022","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.imj.2025.100211_bib0007","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S2213-8587(16)30081-X","article-title":"The global diabetes epidemic: what does it mean for infectious diseases in tropical countries","volume":"5","author":"van Crevel","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"5","key":"10.1016\/j.imj.2025.100211_bib0008","first-page":"442","article-title":"Type 2 diabetes and its impact on the immune system","volume":"16","author":"Berbudi","year":"2020","journal-title":"Curr Diabetes Rev"},{"issue":"8","key":"10.1016\/j.imj.2025.100211_bib0009","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1590\/S0100-879X2006005000143","article-title":"Neutrophil function and metabolism in individuals with diabetes mellitus","volume":"40","author":"Alba-Loureiro","year":"2007","journal-title":"Braz J Med Biol Res"},{"key":"10.1016\/j.imj.2025.100211_bib0010","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.678771","article-title":"A bittersweet response to infection in diabetes; targeting neutrophils to modify inflammation and improve host immunity","volume":"12","author":"Dowey","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.imj.2025.100211_bib0011","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2023.1076690","article-title":"Spontaneous NETosis in diabetes: a role of hyperglycemia mediated ROS and autophagy","volume":"10","author":"Farhan","year":"2023","journal-title":"Front Med"},{"issue":"2","key":"10.1016\/j.imj.2025.100211_bib0012","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.amjms.2015.11.011","article-title":"The effect of short-term hyperglycemia on the innate immune system","volume":"351","author":"Jafar","year":"2016","journal-title":"Am J Med Sci"},{"issue":"Suppl 6","key":"10.1016\/j.imj.2025.100211_bib0013","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/dom.16460","article-title":"Type 1 diabetes: a guide to autoimmune mechanisms for clinicians","volume":"27","author":"Mauvais","year":"2025","journal-title":"Diabetes Obes Metab"},{"issue":"7","key":"10.1016\/j.imj.2025.100211_bib0014","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1007\/s00125-024-06102-x","article-title":"Diabetes and infection: review of the epidemiology, mechanisms and principles of treatment","volume":"67","author":"Holt","year":"2024","journal-title":"Diabetologia"},{"issue":"2","key":"10.1016\/j.imj.2025.100211_bib0015","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/imm.12394","article-title":"Immunological mechanisms contributing to the double burden of diabetes and intracellular bacterial infections","volume":"144","author":"Hodgson","year":"2015","journal-title":"Immunology"},{"key":"10.1016\/j.imj.2025.100211_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2021.108727","article-title":"Natural killer cells play an important role in virus infection control: antiviral mechanism, subset expansion and clinical application","volume":"227","author":"Zuo","year":"2021","journal-title":"Clin Immunol"},{"key":"10.1016\/j.imj.2025.100211_bib0017","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.958430","article-title":"Immunological balance between Treg and Th17 lymphocytes as a key element of type 1 diabetes progression in children","volume":"13","author":"Starosz","year":"2022","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.imj.2025.100211_bib0018","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.2337\/dbi18-0058","article-title":"Function, failure, and the future potential of tregs in type 1 diabetes","volume":"70","author":"Bettini","year":"2021","journal-title":"Diabetes"},{"issue":"6","key":"10.1016\/j.imj.2025.100211_bib0019","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.mpaic.2024.04.003","article-title":"Immune response to infection","volume":"25","author":"Cumming","year":"2024","journal-title":"Anaesth Intensive Care Med"},{"issue":"5","key":"10.1016\/j.imj.2025.100211_bib0020","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1007\/s00125-024-06106-7","article-title":"Interferons are key cytokines acting on pancreatic islets in type 1 diabetes","volume":"67","author":"Coomans de Brach\u00e8ne","year":"2024","journal-title":"Diabetologia"},{"issue":"7","key":"10.1016\/j.imj.2025.100211_bib0021","doi-asserted-by":"crossref","first-page":"848","DOI":"10.3390\/biom14070848","article-title":"Role of type I interferons during mycobacterium tuberculosis and HIV infections","volume":"14","author":"Anes","year":"2024","journal-title":"Biomolecules"},{"issue":"7","key":"10.1016\/j.imj.2025.100211_bib0022","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.3390\/ijms26073106","article-title":"The role and potential application of IL-12 in the immune regulation of tuberculosis","volume":"26","author":"Wang","year":"2025","journal-title":"Int J Mol Sci"},{"issue":"9","key":"10.1016\/j.imj.2025.100211_bib0023","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1080\/14787210.2024.2400548","article-title":"Inflammatory response to SARS-CoV 2 and other respiratory viruses","volume":"22","author":"Vi\u00f1\u00e1n Garc\u00e9s","year":"2024","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"6","key":"10.1016\/j.imj.2025.100211_bib0024","doi-asserted-by":"crossref","first-page":"L839","DOI":"10.1152\/ajplung.00250.2024","article-title":"Disruption of immune responses by type 1 diabetes exacerbates SARS-CoV-2 mediated lung injury","volume":"327","author":"Kass-Gergi","year":"2024","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"6","key":"10.1016\/j.imj.2025.100211_bib0025","doi-asserted-by":"crossref","first-page":"774","DOI":"10.3390\/v17060774","article-title":"Finetuning type I interferon signaling to enhance T cell immunity in HIV infection","volume":"17","author":"Mu","year":"2025","journal-title":"Viruses"},{"issue":"7","key":"10.1016\/j.imj.2025.100211_bib0026","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1002\/eji.201848037","article-title":"Diabetes alters immune response patterns to acute melioidosis in humans","volume":"49","author":"Kronsteiner","year":"2019","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.imj.2025.100211_bib0027","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.semcdb.2022.09.004","article-title":"Epigenetic regulation of inflammation in insulin resistance","volume":"154","author":"Klimczak","year":"2024","journal-title":"Semin Cell Dev Biol"},{"key":"10.1016\/j.imj.2025.100211_bib0028","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/254874","article-title":"Altered immune regulation in type 1 diabetes","volume":"2013","author":"Z\u00f3ka","year":"2013","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.imj.2025.100211_bib0029","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/6196532","article-title":"Immunological impacts of diabetes on the susceptibility of mycobacterium tuberculosis","volume":"2019","author":"Ayelign","year":"2019","journal-title":"J Immunol Res"},{"issue":"4","key":"10.1016\/j.imj.2025.100211_bib0030","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s10096-011-1337-4","article-title":"The impact of diabetes on the pathogenesis of sepsis","volume":"31","author":"Koh","year":"2012","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.imj.2025.100211_bib0031","series-title":"Cells of the Immune System","article-title":"Neutrophil function impairment is a host susceptibility factor to bacterial infection in diabetes","author":"Insuela","year":"2020"},{"issue":"3","key":"10.1016\/j.imj.2025.100211_bib0032","doi-asserted-by":"crossref","first-page":"971","DOI":"10.3390\/biomedicines11030971","article-title":"Insight on infections in diabetic setting","volume":"11","author":"Pari","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.imj.2025.100211_bib0033","doi-asserted-by":"crossref","unstructured":"Citro A., Campo F., Dugnani E., et al. Innate immunity mediated inflammation and beta cell function: neighbors or enemies Front Endocrinol. 2020, 11: 606332. doi:10.3389\/fendo.2020.606332.","DOI":"10.3389\/fendo.2020.606332"},{"issue":"3","key":"10.1016\/j.imj.2025.100211_bib0034","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/s41574-020-00443-4","article-title":"Type 1 diabetes mellitus as a disease of the \u03b2-cell (do not blame the immune system)","volume":"17","author":"Roep","year":"2021","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.imj.2025.100211_bib0035","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.991716","article-title":"How dysregulation of the immune system promotes diabetes mellitus and cardiovascular risk complications","volume":"9","author":"Girard","year":"2022","journal-title":"Front Cardiovasc Med"},{"issue":"6","key":"10.1016\/j.imj.2025.100211_bib0036","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.2337\/db20-0573","article-title":"The role of TCF7L2 in type 2 diabetes","volume":"70","author":"Del Bosque-Plata","year":"2021","journal-title":"Diabetes"},{"issue":"4","key":"10.1016\/j.imj.2025.100211_bib0037","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1080\/13102818.2018.1438211","article-title":"Possible role of TCF7L2 in the pathogenesis of type 2 diabetes mellitus","volume":"32","author":"Huang","year":"2018","journal-title":"Biotechnol Biotechnol Equip"},{"issue":"3","key":"10.1016\/j.imj.2025.100211_bib0038","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1002\/oby.20606","article-title":"FTO genetic variants and risk of obesity and type 2 diabetes: a meta-analysis of 28, 394 Indians","volume":"22","author":"Vasan","year":"2014","journal-title":"Obesity"},{"key":"10.1016\/j.imj.2025.100211_bib0039","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2021.145585","article-title":"Association of FTO gene methylation with incident type 2 diabetes mellitus: a nested case-control study","volume":"786","author":"Huang","year":"2021","journal-title":"Gene"},{"issue":"3","key":"10.1016\/j.imj.2025.100211_bib0040","doi-asserted-by":"crossref","first-page":"E600","DOI":"10.1210\/jc.2012-3644","article-title":"Common genetic variants in peroxisome proliferator-activated receptor-\u03b3 (PPARG) and type 2 diabetes risk among Women\u2019s Health Initiative postmenopausal women","volume":"98","author":"Chan","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.imj.2025.100211_bib0041","doi-asserted-by":"crossref","first-page":"277","DOI":"10.2174\/1573399814666180912130401","article-title":"Association of PPARG gene polymorphisms Pro12Ala with type 2 diabetes mellitus: a meta-analysis","volume":"15","author":"Li","year":"2019","journal-title":"Curr Diabetes Rev"},{"issue":"2","key":"10.1016\/j.imj.2025.100211_bib0042","doi-asserted-by":"crossref","first-page":"132","DOI":"10.2174\/1573399812666151123104540","article-title":"Genetic, epigenetic and biological effects of zinc transporter (SLC30A8) in type 1 and type 2 diabetes","volume":"13","author":"Gu","year":"2017","journal-title":"Curr Diabetes Rev"},{"key":"10.1016\/j.imj.2025.100211_bib0043","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.2147\/DMSO.S229987","article-title":"TNF-\u03b1 (-308) gene polymorphism and type 2 diabetes mellitus in Ethiopian diabetes patients","volume":"12","author":"Ayelign","year":"2019","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"12","key":"10.1016\/j.imj.2025.100211_bib0044","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20191301","article-title":"The association of TNF-\u03b1-308G\/A and-238G\/a polymorphisms with type 2 diabetes mellitus: a meta-analysis","volume":"39","author":"Guo","year":"2019","journal-title":"Biosci Rep"},{"key":"10.1016\/j.imj.2025.100211_bib0045","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1122255","article-title":"Immunologic, metabolic and genetic impact of diabetes on tuberculosis susceptibility","volume":"14","author":"Ssekamatte","year":"2023","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.imj.2025.100211_bib0046","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.coph.2013.05.002","article-title":"Diabetic kidney disease and immune modulation","volume":"13","author":"Hickey","year":"2013","journal-title":"Curr Opin Pharmacol"},{"issue":"4","key":"10.1016\/j.imj.2025.100211_bib0047","first-page":"559","article-title":"Toll-like receptor 2 (TLR-2) gene polymorphisms in type 2 diabetes mellitus","volume":"20","author":"Ermi\u015f Karaali","year":"2019","journal-title":"Cell J"},{"issue":"10","key":"10.1016\/j.imj.2025.100211_bib0048","doi-asserted-by":"crossref","first-page":"e1466","DOI":"10.1002\/mgg3.1466","article-title":"Quantitative assessment of TLR4 gene polymorphisms and T2DM risk: a meta-analysis","volume":"8","author":"Fan","year":"2020","journal-title":"Mol Genet Genom Med"},{"key":"10.1016\/j.imj.2025.100211_bib0049","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/5271295","article-title":"Pattern recognition receptor-mediated chronic inflammation in the development and progression of obesity-related metabolic diseases","volume":"2019","author":"Yu","year":"2019","journal-title":"Mediat Inflamm"},{"issue":"7","key":"10.1016\/j.imj.2025.100211_bib0050","doi-asserted-by":"crossref","first-page":"e152","DOI":"10.1371\/journal.pmed.0050152","article-title":"Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies","volume":"5","author":"Jeon","year":"2008","journal-title":"PLoS Med"},{"issue":"2","key":"10.1016\/j.imj.2025.100211_bib0051","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s10096-007-0395-0","article-title":"The role of interferon-gamma in the increased tuberculosis risk in type 2 diabetes mellitus","volume":"27","author":"Stalenhoef","year":"2008","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"1","key":"10.1016\/j.imj.2025.100211_bib0052","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/imr.12902","article-title":"NOD1 and NOD2 in inflammatory and infectious diseases","volume":"297","author":"Trindade","year":"2020","journal-title":"Immunol Rev"},{"issue":"2","key":"10.1016\/j.imj.2025.100211_bib0053","doi-asserted-by":"crossref","first-page":"e303","DOI":"10.1002\/ctm2.303","article-title":"Identification of distinct metabolic characteristics of pneumonia in type 2 diabetes mellitus","volume":"11","author":"Huang","year":"2021","journal-title":"Clin Transl Med"},{"issue":"1","key":"10.1016\/j.imj.2025.100211_bib0054","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/jleuko\/qiad070","article-title":"Neutrophil responsiveness to IL-10 impairs clearance of Streptococcus pneumoniae from the lungs","volume":"115","author":"Horn","year":"2024","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.imj.2025.100211_bib0055","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.812940","article-title":"ACE and ACE2 gene variants are associated with severe outcomes of COVID-19 in men","volume":"13","author":"Mart\u00ednez-G\u00f3mez","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.imj.2025.100211_bib0056","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2020.629933","article-title":"Why is COVID-19 more severe in patients with diabetes the role of angiotensin-converting enzyme 2, endothelial dysfunction and the immunoinflammatory system","volume":"7","author":"Roberts","year":"2021","journal-title":"Front Cardiovasc Med"},{"issue":"3","key":"10.1016\/j.imj.2025.100211_bib0057","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3233\/HAB-230007","article-title":"Evaluation of IL-6 and IL-17A gene polymorphisms in Iraqi patients infected with COVID-19 and type 2 diabetes mellitus","volume":"31","author":"Khalaf","year":"2023","journal-title":"Hum Antibodies"},{"issue":"4","key":"10.1016\/j.imj.2025.100211_bib0058","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.dsx.2020.04.004","article-title":"Diabetes in COVID-19: prevalence, pathophysiology, prognosis and practical considerations","volume":"14","author":"Singh","year":"2020","journal-title":"Diabetes Metab Syndr"},{"key":"10.1016\/j.imj.2025.100211_bib0059","doi-asserted-by":"crossref","DOI":"10.3389\/fddsv.2022.899239","article-title":"Furin and COVID-19: structure, function and chemoinformatic analysis of representative active site inhibitors","volume":"2","author":"Villoutreix","year":"2022","journal-title":"Front Drug Discov"},{"issue":"4","key":"10.1016\/j.imj.2025.100211_bib0060","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1189\/jlb.0313142","article-title":"High glucose enhances HIV entry into T cells through upregulation of CXCR4","volume":"94","author":"Lan","year":"2013","journal-title":"J Leukoc Biol"},{"issue":"1","key":"10.1016\/j.imj.2025.100211_bib0061","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3390\/biomedicines11010159","article-title":"The many faces of immune activation in HIV-1 infection: a multifactorial interconnection","volume":"11","author":"Mazzuti","year":"2023","journal-title":"Biomedicines"},{"issue":"6","key":"10.1016\/j.imj.2025.100211_bib0062","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1615\/CritRevImmunol.v26.i6.40","article-title":"Immunological protection against mycobacterium tuberculosis infection","volume":"26","author":"Yoshikai","year":"2006","journal-title":"Crit Rev Immunol"},{"issue":"1","key":"10.1016\/j.imj.2025.100211_bib0063","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2217\/fvl.12.123","article-title":"HIV-1 and the immune response to TB","volume":"8","author":"Walker","year":"2013","journal-title":"Future Virol"},{"issue":"9","key":"10.1016\/j.imj.2025.100211_bib0064","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1111\/cmi.12480","article-title":"The innate immune response in human tuberculosis","volume":"17","author":"Lerner","year":"2015","journal-title":"Cell Microbiol"},{"key":"10.1016\/j.imj.2025.100211_bib0065","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1146\/annurev-immunol-032712-095939","article-title":"The immune response in tuberculosis","volume":"31","author":"O\u2019Garra","year":"2013","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.imj.2025.100211_bib0066","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1146\/annurev-immunol-032712-100022","article-title":"The formation and function of granulomas","volume":"36","author":"Pag\u00e1n","year":"2018","journal-title":"Annu Rev Immunol"},{"issue":"1","key":"10.1016\/j.imj.2025.100211_bib0067","doi-asserted-by":"crossref","first-page":"8","DOI":"10.14341\/DM7775","article-title":"Immunity-mediated diseases and human immunogenetics (accomplishments and prospects)","volume":"19","author":"Dedov","year":"2016","journal-title":"Diabetes Mellit"},{"issue":"11","key":"10.1016\/j.imj.2025.100211_bib0068","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/s41574-019-0254-y","article-title":"The heterogeneous pathogenesis of type 1 diabetes mellitus","volume":"15","author":"Ilonen","year":"2019","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.imj.2025.100211_bib0069","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.3389\/fimmu.2019.02654","article-title":"Norovirus changes susceptibility to type 1 diabetes by altering intestinal microbiota and immune cell functions","volume":"10","author":"Pearson","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.imj.2025.100211_bib0070","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s12038-022-00309-z","article-title":"Identification of perturbed pathways rendering susceptibility to tuberculosis in type 2 diabetes mellitus patients using BioNSi simulation of integrated networks of implicated human genes","volume":"47","author":"Rani","year":"2022","journal-title":"J Biosci"},{"issue":"1","key":"10.1016\/j.imj.2025.100211_bib0071","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nrneph.2015.175","article-title":"Innate immunity in diabetes and diabetic nephropathy","volume":"12","author":"Jun","year":"2016","journal-title":"Nat Rev Nephrol"},{"issue":"2","key":"10.1016\/j.imj.2025.100211_bib0072","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s00125-011-2387-y","article-title":"Innate immunity, insulin resistance and type 2 diabetes","volume":"55","author":"Fern\u00e1ndez-Real","year":"2012","journal-title":"Diabetologia"},{"issue":"9","key":"10.1016\/j.imj.2025.100211_bib0073","doi-asserted-by":"crossref","first-page":"922","DOI":"10.2337\/diab.34.9.922","article-title":"Virus-induced diabetes mellitus: no evidence for immune mechanisms in the destruction of \u03b2-cells by the d-variant of encephalomyocarditis virus","volume":"34","author":"Yoon","year":"1985","journal-title":"Diabetes"},{"key":"10.1016\/j.imj.2025.100211_bib0074","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2021.559595","article-title":"Susceptibility for some infectious diseases in patients with diabetes: the key role of glycemia","volume":"9","author":"Ch\u00e1vez-Reyes","year":"2021","journal-title":"Front Public Health"},{"issue":"7","key":"10.1016\/j.imj.2025.100211_bib0075","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1002\/stem.3357","article-title":"Mesenchymal stromal cell-mediated immune regulation: a promising remedy in the therapy of type 2 diabetes mellitus","volume":"39","author":"Chen","year":"2021","journal-title":"Stem Cells"},{"key":"10.1016\/j.imj.2025.100211_bib0076","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1229823","article-title":"A single center case series of immune checkpoint inhibitor-induced type 1 diabetes mellitus, patterns of disease onset and long-term clinical outcome","volume":"14","author":"Marsiglio","year":"2023","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.imj.2025.100211_bib0077","first-page":"5","article-title":"Immunological mechanisms of increased susceptibility to COVID-19 disease and its severe course in patients with diabetes mellitus type 2 and obesity","volume":"95","author":"Zak","year":"2023","journal-title":"UkrBiochemJ"},{"issue":"1","key":"10.1016\/j.imj.2025.100211_bib0078","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s13287-017-0542-1","article-title":"Immune response after autologous hematopoietic stem cell transplantation in type 1 diabetes mellitus","volume":"8","author":"Ye","year":"2017","journal-title":"Stem Cell Res Ther"},{"issue":"8","key":"10.1016\/j.imj.2025.100211_bib0079","first-page":"5","article-title":"Diabetic animal models with infectious diseases: focus on the dysfunction of immune system","author":"LiTzu Yeh","year":"2014","journal-title":"J Diabetes Metab"},{"issue":"8","key":"10.1016\/j.imj.2025.100211_bib0080","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.micinf.2020.03.004","article-title":"Increased susceptibility to mycobacterium tuberculosis infection in a diet-induced murine model of type 2 diabetes","volume":"22","author":"Alim","year":"2020","journal-title":"Microbes Infect"},{"issue":"11","key":"10.1016\/j.imj.2025.100211_bib0081","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s11892-017-0933-9","article-title":"Modulation of type 1 diabetes risk by the intestinal microbiome","volume":"17","author":"Knip","year":"2017","journal-title":"Curr Diab Rep"},{"issue":"3","key":"10.1016\/j.imj.2025.100211_bib0082","first-page":"187","article-title":"Impaired immune responses in diabetes mellitus: analysis of the factors and mechanisms involved. Relevance to the increased susceptibility of diabetic patients to specific infections","volume":"18","author":"Moutschen","year":"1992","journal-title":"Diabete Metab"},{"issue":"4","key":"10.1016\/j.imj.2025.100211_bib0083","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s11892-018-0984-6","article-title":"Role of the immune system in diabetic kidney disease","volume":"18","author":"Hickey","year":"2018","journal-title":"Curr Diab Rep"},{"issue":"6","key":"10.1016\/j.imj.2025.100211_bib0084","doi-asserted-by":"crossref","first-page":"904","DOI":"10.4103\/2230-8210.102989","article-title":"Role of immune system modulation in prevention of type 1 diabetes mellitus","volume":"16","author":"Hassan","year":"2012","journal-title":"Indian J Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.imj.2025.100211_bib0085","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/imm.12762","article-title":"Influence of diabetes mellitus on immunity to human tuberculosis","volume":"152","author":"Kumar Nathella","year":"2017","journal-title":"Immunology"},{"issue":"5","key":"10.1016\/j.imj.2025.100211_bib0086","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s00125-002-0781-1","article-title":"Genetic control of autoimmunity in type I diabetes and associated disorders","volume":"45","author":"Redondo","year":"2002","journal-title":"Diabetologia"},{"issue":"10","key":"10.1016\/j.imj.2025.100211_bib0087","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1111\/all.14462","article-title":"Immunology of COVID-19: mechanisms, clinical outcome, diagnostics, and perspectives-a report of the European Academy of Allergy and Clinical Immunology (EAACI)","volume":"75","author":"Sokolowska","year":"2020","journal-title":"Allergy"},{"key":"10.1016\/j.imj.2025.100211_bib0088","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2020.108427","article-title":"COVID-19 pathophysiology: a review","volume":"215","author":"Yuki","year":"2020","journal-title":"Clin Immunol"},{"key":"10.1016\/j.imj.2025.100211_bib0089","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.coviro.2021.11.002","article-title":"Host cell-intrinsic innate immune recognition of SARS-CoV-2","volume":"52","author":"Madden","year":"2022","journal-title":"Curr Opin Virol"},{"issue":"10","key":"10.1016\/j.imj.2025.100211_bib0090","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/s41577-020-00429-3","article-title":"The type I interferon response in COVID-19: implications for treatment","volume":"20","author":"Lee","year":"2020","journal-title":"Nat Rev Immunol"},{"issue":"6504","key":"10.1016\/j.imj.2025.100211_bib0091","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1126\/science.abc6027","article-title":"Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients","volume":"369","author":"Hadjadj","year":"2020","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.imj.2025.100211_bib0092","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1001\/jamainternmed.2020.0994","article-title":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan","volume":"180","author":"Wu","year":"2020","journal-title":"JAMA Intern Med"},{"issue":"4","key":"10.1016\/j.imj.2025.100211_bib0093","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1684\/ecn.2020.0456","article-title":"Extensive longitudinal immune profiling reveals sustained innate immune activation in COVID-19 patients with unfavorable outcome","volume":"31","author":"Schrijver","year":"2020","journal-title":"Eur Cytokine Netw"},{"key":"10.1016\/j.imj.2025.100211_bib0094","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.966344","article-title":"Infectious diseases associated with pediatric type 1 diabetes mellitus: a narrative review","volume":"13","author":"Piccolo","year":"2022","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.imj.2025.100211_bib0095","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.addr.2021.01.011","article-title":"Modulating the foreign body response of implants for diabetes treatment","volume":"174","author":"Kharbikar","year":"2021","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.imj.2025.100211_bib0096","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.886736","article-title":"Functional impact of risk gene variants on the autoimmune responses in type 1 diabetes","volume":"13","author":"Gootjes","year":"2022","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.imj.2025.100211_bib0097","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1189\/jlb.3MR1115-500R","article-title":"Type 1 diabetes genetic susceptibility and dendritic cell function: potential targets for treatment","volume":"100","author":"Hotta-Iwamura","year":"2016","journal-title":"J Leukoc Biol"},{"issue":"8","key":"10.1016\/j.imj.2025.100211_bib0098","doi-asserted-by":"crossref","first-page":"4261","DOI":"10.3390\/ijms22084261","article-title":"Gestational diabetes mellitus and maternal immune dysregulation: what we know so far","volume":"22","author":"McElwain","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10.1016\/j.imj.2025.100211_bib0099","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1016\/j.diabres.2013.12.042","article-title":"Cohort study of diabetes in HIV-infected adult patients: evaluating the effect of diabetes mellitus on immune reconstitution","volume":"103","author":"Moyo","year":"2014","journal-title":"Diabetes Res Clin Pr"},{"issue":"5","key":"10.1016\/j.imj.2025.100211_bib0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.dsx.2021.102235","article-title":"Post COVID-19 syndrome (\u201clong COVID\u201d) and diabetes: challenges in diagnosis and management","volume":"15","author":"Raveendran","year":"2021","journal-title":"Diabetes Metab Syndr"},{"key":"10.1016\/j.imj.2025.100211_bib0101","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/7394378","article-title":"Diabetes mellitus and COVID-19: associations and possible mechanisms","volume":"2021","author":"Li","year":"2021","journal-title":"Int J Endocrinol"},{"issue":"5","key":"10.1016\/j.imj.2025.100211_bib0102","doi-asserted-by":"crossref","first-page":"325","DOI":"10.6065\/apem.2346228.114","article-title":"Post-COVID syndrome and type 2 diabetes mellitus in Kazakhstan: clinical manifestations and vaccine efficacy","volume":"29","author":"Altynbekova","year":"2024","journal-title":"Ann Pediatr Endocrinol Metab"},{"key":"10.1016\/j.imj.2025.100211_bib0103","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2022.110202","article-title":"The bidirectional association between diabetes and long-COVID-19 - A systematic review","volume":"195","author":"Harding","year":"2023","journal-title":"Diabetes Res Clin Pr"},{"key":"10.1016\/j.imj.2025.100211_bib0104","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102607","article-title":"The prevalence of long COVID in people with diabetes mellitus-evidence from a UK cohort","volume":"71","author":"Heald","year":"2024","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.imj.2025.100211_bib0105","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1167087","article-title":"Post-COVID-19 syndrome and diabetes mellitus: a propensity-matched analysis of the International HOPE-II COVID-19 Registry","volume":"14","author":"Abumayyaleh","year":"2023","journal-title":"Front Endocrinol"},{"issue":"11","key":"10.1016\/j.imj.2025.100211_bib0106","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/hiv.13021","article-title":"The role of CD8 T cells in controlling HIV beyond the antigen-specific face","volume":"21","author":"Zhang","year":"2020","journal-title":"HIV Med"},{"issue":"3","key":"10.1016\/j.imj.2025.100211_bib0107","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.jid.2022.07.035","article-title":"HIV-associated immune dysregulation in the skin: a crucible for exaggerated inflammation and hypersensitivity","volume":"143","author":"Chimbetete","year":"2023","journal-title":"J Invest Dermatol"},{"issue":"8","key":"10.1016\/j.imj.2025.100211_bib0108","doi-asserted-by":"crossref","first-page":"e2961","DOI":"10.1371\/journal.pone.0002961","article-title":"HIV-induced type I interferon and tryptophan catabolism drive T cell dysfunction despite phenotypic activation","volume":"3","author":"Boasso","year":"2008","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.imj.2025.100211_bib0109","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0203419","article-title":"CD72\/CD100 and PD-1\/PD-L1 markers are increased on T and B cells in HIV-1+ viremic individuals, and CD72\/CD100 axis is correlated with T-cell exhaustion","volume":"13","author":"Correa-Rocha","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.imj.2025.100211_bib0110","doi-asserted-by":"crossref","DOI":"10.1071\/SH24056","article-title":"Global, regional, and national burdens of HIV\/AIDS acquired through sexual transmission 1990-2019: an observational study","volume":"21","author":"Wu","year":"2024","journal-title":"Sex Health"},{"issue":"5","key":"10.1016\/j.imj.2025.100211_bib0111","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1080\/09540121.2019.1695727","article-title":"Diabetes mellitus in people living with HIV\/AIDS: prevalence and associated risk factors","volume":"32","author":"da Cunha","year":"2020","journal-title":"AIDS Care"},{"issue":"5","key":"10.1016\/j.imj.2025.100211_bib0112","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0250676","article-title":"Diagnosis, risk factors and management of diabetes mellitus in HIV-infected persons in France: a real-life setting study","volume":"16","author":"Kousignian","year":"2021","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.imj.2025.100211_bib0113","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1186\/s12889-021-10318-6","article-title":"Prevalence and predictors of diabetes mellitus among persons living with HIV: a retrospective cohort study conducted in 4 public healthcare facilities in KwaZulu-Natal","volume":"21","author":"Umar","year":"2021","journal-title":"BMC Public Health"},{"key":"10.1016\/j.imj.2025.100211_bib0114","doi-asserted-by":"crossref","first-page":"580","DOI":"10.3389\/fimmu.2017.00580","article-title":"Pathophysiology of CD4+ T-cell depletion in HIV-1 and HIV-2 infections","volume":"8","author":"Vidya Vijayan","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.imj.2025.100211_bib0115","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.613930","article-title":"The role of HIV infection in the pathophysiology of gestational diabetes mellitus and hypertensive disorders of pregnancy","volume":"8","author":"Phoswa","year":"2021","journal-title":"Front Cardiovasc Med"},{"issue":"5","key":"10.1016\/j.imj.2025.100211_bib0116","doi-asserted-by":"crossref","first-page":"81","DOI":"10.5923\/j.diabetes.20120105.02","article-title":"Magnitude of diabetes comorbidity among people living with HIV: a systematic review","volume":"1","author":"NigatuHaregu","year":"2012","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.imj.2025.100211_bib0117","doi-asserted-by":"crossref","first-page":"120","DOI":"10.4314\/ahs.v23i1.14","article-title":"Evaluation of some immune and inflammatory responses in diabetes and HIV co-morbidity","volume":"23","author":"Chukwuanukwu","year":"2023","journal-title":"Afr Health Sci"},{"issue":"2","key":"10.1016\/j.imj.2025.100211_bib0118","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/path.4449","article-title":"HIV and the spectrum of human disease","volume":"235","author":"Lucas","year":"2015","journal-title":"J Pathol"},{"issue":"1","key":"10.1016\/j.imj.2025.100211_bib0119","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12875-024-02261-3","article-title":"Diabetes mellitus and associated factors among HIV-positive patients at primary health care facilities in Harare, Zimbabwe: a descriptive cross-sectional study","volume":"25","author":"Chireshe","year":"2024","journal-title":"BMC Prim Care"},{"issue":"1","key":"10.1016\/j.imj.2025.100211_bib0120","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1186\/s12913-021-06670-3","article-title":"The comorbidity of HIV, hypertension and diabetes: a qualitative study exploring the challenges faced by healthcare providers and patients in selected urban and rural health facilities where the ICDM model is implemented in South Africa","volume":"21","author":"Godongwana","year":"2021","journal-title":"BMC Health v Res"},{"issue":"5","key":"10.1016\/j.imj.2025.100211_bib0121","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s11892-021-01382-8","article-title":"Diabetes in people with HIV","volume":"21","author":"Sarkar","year":"2021","journal-title":"Curr Diabetes Rep"},{"issue":"4","key":"10.1016\/j.imj.2025.100211_bib0122","doi-asserted-by":"crossref","first-page":"905","DOI":"10.3390\/diagnostics12040905","article-title":"Combination antiretroviral therapy (cART) in diabetes exacerbates diabetogenic effects on hippocampal microstructure, neurogenesis and cytokine perturbation in male sprague dawley rats","volume":"12","author":"Asouzu Johnson","year":"2022","journal-title":"Diagnostics"},{"issue":"3","key":"10.1016\/j.imj.2025.100211_bib0123","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1093\/cid\/ciu779","article-title":"Diagnosing and managing diabetes in HIV-infected patients: current concepts","volume":"60","author":"Monroe","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.imj.2025.100211_bib0124","doi-asserted-by":"crossref","first-page":"396","DOI":"10.3390\/vaccines12040396","article-title":"Vaccines induce homeostatic immunity, generating several secondary benefits","volume":"12","author":"Arunachalam","year":"2024","journal-title":"Vaccines"},{"key":"10.1016\/j.imj.2025.100211_bib0125","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1577523","article-title":"Glycemic control and vaccine response: the role of mucosal immunity after vaccination in diabetic patients","volume":"16","author":"Mojaddidi","year":"2025","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.imj.2025.100211_bib0126","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1021\/acsinfecdis.5c00001","article-title":"Recent advances in immunotherapeutic and vaccine-based approaches for the treatment of drug-resistant bacterial infections","volume":"11","author":"Odoom","year":"2025","journal-title":"ACS Infect Dis"},{"issue":"5","key":"10.1016\/j.imj.2025.100211_bib0127","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.133788","article-title":"BCG vaccination reduces the mortality of mycobacterium tuberculosis-infected type 2 diabetes mellitus mice","volume":"5","author":"Radhakrishnan","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.imj.2025.100211_bib0128","doi-asserted-by":"crossref","first-page":"332","DOI":"10.3389\/fmicb.2020.00332","article-title":"BCG as a case study for precision vaccine development: lessons from vaccine heterogeneity, trained immunity, and immune ontogeny","volume":"11","author":"Angelidou","year":"2020","journal-title":"Front Microbiol"},{"key":"10.1016\/j.imj.2025.100211_bib0129","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.3389\/fimmu.2020.01806","article-title":"The systematic review and meta-analysis on the immunogenicity and safety of the tuberculosis subunit vaccines M72\/AS01(E) and MVA85A","volume":"11","author":"Ullah","year":"2020","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.imj.2025.100211_bib0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.dsx.2022.102406","article-title":"Antibody response following SARS-CoV-2 vaccination among patients with type 2 diabetes mellitus: a systematic review","volume":"16","author":"Soetedjo","year":"2022","journal-title":"Diabetes Metab Syndr"},{"issue":"1","key":"10.1016\/j.imj.2025.100211_bib0131","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/dom.14547","article-title":"Does poor glycaemic control affect the immunogenicity of the COVID-19 vaccination in patients with type 2 diabetes: the CAVEAT study","volume":"24","author":"Marfella","year":"2022","journal-title":"Diabetes Obes Metab"},{"issue":"7","key":"10.1016\/j.imj.2025.100211_bib0132","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.3390\/vaccines11071203","article-title":"Assessment of the immune response in patients with insulin resistance, obesity, and diabetes to COVID-19 vaccination","volume":"11","author":"Warpechowski","year":"2023","journal-title":"Vaccines"},{"issue":"2","key":"10.1016\/j.imj.2025.100211_bib0133","doi-asserted-by":"crossref","first-page":"148","DOI":"10.3390\/vaccines13020148","article-title":"Progress and challenges in HIV-1 vaccine research: a comprehensive overview","volume":"13","author":"Boomgarden","year":"2025","journal-title":"Vaccines"},{"issue":"6","key":"10.1016\/j.imj.2025.100211_bib0134","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1177\/01939459211005710","article-title":"Assessing vaccine protection for older adults with diabetes: a systematic review","volume":"44","author":"Almasri","year":"2022","journal-title":"West J Nurs Res"},{"issue":"4","key":"10.1016\/j.imj.2025.100211_bib0135","doi-asserted-by":"crossref","DOI":"10.1111\/dme.14774","article-title":"The change in glycaemic control immediately after COVID-19 vaccination in people with type 1 diabetes","volume":"39","author":"Heald","year":"2022","journal-title":"Diabet Med"}],"container-title":["Infectious Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772431X25000504?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772431X25000504?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T07:45:30Z","timestamp":1766389530000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772431X25000504"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":135,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S2772431X25000504"],"URL":"https:\/\/doi.org\/10.1016\/j.imj.2025.100211","relation":{},"ISSN":["2772-431X"],"issn-type":[{"value":"2772-431X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immune dysregulation in type 2 diabetes mellitus: Implications for tuberculosis, COVID-19, and HIV\/AIDS","name":"articletitle","label":"Article Title"},{"value":"Infectious Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imj.2025.100211","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd on behalf of Tsinghua University Press.","name":"copyright","label":"Copyright"}],"article-number":"100211"}}